Clinical bottom line
AI-enhanced imaging techniques, particularly those employing deep learning algorithms applied to 3D CT scans, show promising potential for early detection of radiation-induced lung injury (RILI). Early identification of RILI can facilitate timely intervention to mitigate progression and improve patient outcomes following thoracic radiotherapy. Current evidence, primarily from preclinical models and emerging clinical studies, suggests that AI can detect subtle imaging changes before conventional radiological signs become apparent. However, clinical validation and integration into routine practice remain in early stages (Wang et al., 2025; Devihosur et al., 2025).
What the evidence shows
Wang et al. (2025) analyzed CT features of radiation-induced lung injury in patients undergoing stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer. They identified specific early CT imaging prognosticators correlated with subsequent RILI severity, supporting the utility of detailed imaging analysis in risk stratification.
Devihosur et al. (2025) demonstrated the application of AI-enhanced deep learning models on 3D CT imaging for early lung cancer detection, highlighting the broader potential of AI to detect subtle lung parenchymal changes, which may be extrapolated to early RILI detection.
Saito et al. (2012) used micro-CT imaging in a murine model to detect and assess early-phase radiation-induced lung injury, showing that imaging biomarkers can identify injury before clinical symptoms develop.
Zanette et al. (2017) employed hyperpolarized 129Xe chemical shift imaging in a rat model to detect regional RILI, providing proof-of-concept for advanced imaging modalities in early injury detection.
These studies collectively underscore the evolving role of AI and advanced imaging techniques in identifying early lung tissue changes post-radiation.
Caveats and uncertainty
Most evidence arises from preclinical models or retrospective analyses; prospective clinical trials validating AI algorithms for RILI detection are limited.
Heterogeneity in imaging protocols and AI model architectures complicates standardization.
Interpretation of AI findings requires integration with clinical context to avoid overdiagnosis.
Cost, accessibility, and training requirements may limit widespread adoption initially.
Longitudinal studies are needed to correlate early imaging changes detected by AI with clinical outcomes and guide management.
How this may change practice
AI-enhanced imaging could become an integral part of post-radiotherapy surveillance, enabling earlier detection of RILI than conventional imaging interpretation.
Radiologists may use AI tools to augment diagnostic accuracy and quantify subtle lung changes, improving risk stratification.
Early identification of RILI may prompt timely therapeutic interventions, potentially reducing morbidity.
Integration of AI into imaging workflows will require multidisciplinary collaboration and validation.
Clinicians should remain informed about emerging AI applications to optimize patient monitoring after thoracic radiation.